Background/Objective: Calcium is essential for the bone metabolism but daily calcium requirements are not met in a significant proportion of the population. Fortunately, oral calcium supplementation can help to meet these needs; however, the calcium bioavailability depends on the calcium sources. The calcium absorption and bioavailability of dietary supplements from marine sources are not known. The objectives of this study were to evaluate the effects of two marine dietary supplements with a high calcium content: a fishbone powder (Phoscalim) and a ray cartilage hydrolysate (Glycollagene), in comparison with milk, and a placebo (maltodextrin), on calcium metabolism and a biochemical marker of bone resorption, using the oral calcium tolerance test. Subjects: Twenty male volunteers were randomized to eat 836 mg of calcium from different sources compared to maltodextrin during a Latin square study. Serum calcium concentrations and other parameters of the calcium metabolism, such as serum intact parathyroid hormone (iPTH) and serum C telopeptides (s-CTX), were measured after an acute oral calcium load based on the Pak protocol. Results: An increase in serum-corrected calcium areas under the curve (AUC) occurred with Phoscalim and Glycollagene when compared to milk. Significantly lower iPTH concentrations were observed with Glycollagene than with milk at T0 þ 1 h, T0 þ 3 h, T0 þ 6 h and with Phoscalim than with milk at T0 þ 6 h. A significantly lower s-CTX concentration was observed with Glycollagene than with milk and Phoscalim at T0 þ 6 h. Furthermore, the urinary calcium/creatinine ratio increased significantly more with Glycollagen than with milk in T0 h þ 3 h and T3 h þ 6 h. Conclusion: These two dietary supplements from marine sources constitute oral calcium sources when compared to milk on calcium absorption and bone resorption markers on short time.
Introduction
There is a large body of research suggesting that a high calcium intake throughout life is required to maintain bone mass and to minimize bone loss (Dodiuk-Gad et al., 2005; Matkovic et al., 2005) . However, many subjects do not achieve the calcium recommended dietary allowances (Gueguen, 1996; Flynn, 2003) , despite repeated advices.
The average calcium intake in France is around 800 mg/day but 20% of the men under 65 years and 30% of the women under 50 years have intakes lower than two-third of the Recommended Dietary Allowances (Martin 2001) . Moreover, some people cannot have milk products, because they have lactose intolerance or other personal reasons. Therefore, it is necessary to propose non-dairy calcium sources or calcium supplements to reach sufficient calcium daily intakes. Calcium marine sources from fishbone and cartilage are now available; however, the calcium bioavailability of these is unknown. The 24 h urinary calcium excretion or the urinary excretion of calcium after a calcium load may be used as an indirect method to assess calcium absorption but, owing to the very large variability of this measure, it cannot accurately estimate the calcium bioavailability as well as the dual radio and stable isotope method. Similarly, the area under the curve (AUC) method may be used to assess the relative calcium bioavailability between different calcium sources but not as a measure of net absorption (Scopacasa et al., 2004) or the urinary excretion of calcium after a calcium load (Pak et al., 1975; Nicar and Pak, 1985; Gueguen and Pointillart, 2000) . However, dietary calcium also has direct metabolic effects, such as the post-prandial decrease of serum intact parathyroid hormone (iPTH) (Fardellone et al., 1993; Karkkainen et al., 2001; Zikan et al., 2001; Martini and Wood, 2002; Green et al., 2003; Sadideen and Swaminathan, 2004) . The acute oral calcium load may also induce a bone resorption markers decrease, such as serum C telopeptides (s-CTX) (Zikan et al., 2001; Martini and Wood, 2002; Green et al., 2003; Sadideen and Swaminathan, 2004) . Therefore, the effects of oral calcium on iPTH and s-CTX have been used since some years as a method to compare the effects of different sources of oral calcium. The aim of this study was to evaluate the effects of dietary products from two marine sources on calcium metabolism and bone resorption in comparison with milk (which is the reference food for calcium) and maltodextrin using the oral calcium tolerance test.
Subjects and methods

Subjects
Twenty healthy men (mean age: 27.176.2 years) (19 white subjects and one black subject) were selected by the Lille Clinical Investigation Centre. Noninclusion end points were: actual severe somatic or psychiatric diseases, known abnormalities of phospho-calcic metabolism, renal lithiasis, smoking, aversion to milk, drinking of more than three alcohol glasses per day, allergy to fish products, milk or lactose intolerance, drug addicts or nutritional supplements.
The study was approved by the Lille Medicine University ethics committee and all subjects provided a written informed consent.
Study design
The effects of the three calcium sources on calcium metabolism and bone resorption were evaluated by an oral calcium load of 800 mg, which is the lowest level of the French Recommended Dietary Allowances.
The subjects followed a 400 mg/day calcium balanced diet during 3 days before each study session with precise recommendations for this dietary intake and with assessment of the compliance. After an overnight fast, they received at 0800 hours four times, at least 1 week apart, a standardized breakfast (48.7 mg of calcium element; 7.2 g of proteins; 19.6 g of lipids; 73.1 g of carbohydrates; 497 kcal) followed by (according a Latin square randomization) either (1) 11.5 g of a ray cartilage hydrolysate powder (Glycollagene) diluted in 200 ml of water or (2) 3.56 g of a fishbone powder (Phoscalim) diluted in 200 ml of water or (3) 200 ml of skimmed milk with 43.6 g of soluble skimmed milk powder, each of them providing 836.5 mg of calcium element or (4) 20 g of maltodextrin diluted in 200 ml of water (Table 1) . Glycollagen and Phoscalim were prepared by the funding agency of this research. The actual mineral concentration was stated and validated for each product.
The subjects were fasting during the 6 h of the blood and urine measurements.
Blood and urine measurements g-Glutamyl transferase, serum calcium, serum phosphorus, 25-hydroxy-vitamin D (25-OH D), serum albumin and iPTH concentrations were measured in the pre-inclusion visit to select and randomize 20 male subjects.
At each session, blood samples were collected at baseline (T0), T0 þ 1 h, T0 þ 3 h and T0 þ 6 h after the calcium load to measure different serum parameters such as calcium, albumin, phosphorus, iPTH and s-CTX. The AUC were calculated using the Trapezes' method. The corrected serum calcium (CSC) was calculated using the following formula:
Urines were collected during the periods T12-0 h before the calcium load, T0-3 h and T3-T6 h after the calcium load to measure calcium, creatinine, phosphorus, calcium/creatinine ratio and phosphorus/creatinine ratio.
Biochemical analysis
Serum calcium was measured using the o-cusol phtaleine colorimetric method (Hitachi 911, Roche diagnostics).
s-CTX was measured by means of the enzyme-linked immunoassay kit (serum Cross Laps One Step, Osteometer Biotech, herlev; normal range in men, 270-3250 pmol/l). iPTH was measured using the Nichols Advantage Bio-Intact PTH (1-84) immunometric assay (normal range: 4-45 pg/ml). 25-OH D was measured using the Nichols Advantage 25-hydroxyvitamin D chemiluminescence assay (normal range: 13-50 ng/ml).
Statistical analysis
The data were expressed as means7s.d. The Friedman test was performed for comparison between the four groups at Calcium bioavailability from marine calcium sources J-M Lecerf et al each time. When the differences were statistically significant (Po0.05), Wilcoxon tests of differences between means of groups were performed at the global level of probability of 0.05 using the SPSS 11.0 software.
Results
Subjects characteristics
Characteristics of the 20 subjects are presented in Table 2 . The mean age of the volunteers was 27.176.2 years. No difference was observed at baseline between the four groups for each biologic variable measured.
Effects of an acute calcium load on bone resorption and mineral metabolism The mean values7s.d. for CSC, for serum phosphorus, for iPTH, for s-CTX and for global AUC values are given in Tables  3, 4 , 5, 6 and 7. A significant increase of the CSC in the groups milk (Po0.036) and Glycollagen (Po0.009) versus Maltodextrin and Glycollagen (Po0.034) versus Phoscalim, was observed at time T0 þ 1 h. At T0 þ 3 h, CSC was significantly higher in the groups Glycollagen (Po0.003) and Phoscalim (Po0.001) than in the Maltodextrin group. At T0 þ 6 h, CSC has significantly higher in the Phoscalim group (Po0.0035) than in the Maltodextrin group. The AUC values for the three calcium sources confirmed these results showing a significant increase in the Phoscalim group than Maltodextrin group (Table 7) .
A decrease of serum phosphorus was observed at T0 þ 1 h for the four groups, serum phosphorus concentrations were significantly lower for milk (Po0.033) and Maltodextrin (Po0.006) versus P. At T0 þ 3 h, phosphorus concentration increased in the four groups and phosphorus concentrations were significantly higher in milk (Po0.014), Glycollagen (Po0.049) and Phoscalim (Po0.001) groups than in Maltodextrin and in milk (Po0.024) and Phoscalim (Po0.01) groups than in Glycollagen group. The AUC values were in accordance with serum phosphorus concentrations ( Table 7) .
We observed a decrease of iPTH concentrations in the four groups at T0 þ 1 h, with a significantly lower concentration in Glycollagen group than in milk (Po0.0001), Maltodextrin and Phoscalim (Po0.001) groups. It was also observed at T0 þ 3 h. At T0 þ 6 h, the iPTH concentration was lower in Glycollagen versus milk (Po0.003) and Maltodextrin (Po0.001) groups, and with Phoscalim versus milk (Po0.03) and Maltodextrin (Po0.017) groups. Analysis of the response curves and AUC showed the same variations ( Table 7) .
As shown in Table 6 , comparison of the four groups demonstrated no statistical differences in T0 and T0 þ 1 h for s-CTX concentrations. A decrease of s-CTX concentrations in the four groups occurred in T0 þ 1, T0 þ 3 and T0 þ 6 h. At T0 þ 3 h, the s-CTX concentrations were significantly lower in milk and Glycollagen groups than in Maltodextrin (Po0.01) and Phoscalim (Po0.001) groups. These differences persisted in T0 þ 6 h; moreover the s-CTX concentration was significantly lower with Glycollagen than with milk and Phoscalim (Po0.0001). Figure 1 presented the means values for urinary calcium/ creatinine ratio. The urinary calcium/creatinine ratio increased significantly more with Glycollagen than with milk (Po0.01), Phoscalim (Po0.001) and Maltodextrin (Po0.0001) groups during the T0-T3 h period. This difference increased during the T3-T6 h period. This ratio was also higher with Phoscalim (Po0.001) and milk (Po0.0001) groups than with Maltodextrin groups. 
Discussion
This acute oral calcium load showed, through the simultaneous increase in serum calcium and urinary calcium excretion, that the bioavailability of the marine calcium sources is as good (Phoscalim) or better (Glycollagen) as the same intake of dairy calcium from milk. Moreover, the marine calcium load induced a greater decrease of iPTH in Glycollagen group than milk and a greater decrease in bone resorption reflected by s-CTX, since Phoscalim has a nearly similar effect on serum iPTH than milk and a lesser effect on s-CTX than milk.
This first study on the bioavailability (absorption and metabolic effects) of marine calcium has shown results, which are close to other acute oral calcium load studies using Pak's derived methods (Fardellone et al., 1993; Zikan et al., 2001; Green et al., 2003; Sadideen and Swaminathan, 2004) . Although the double label stable isotope technique is often considered as the reference technique (Beck et al., 2003) , its validity depends on several factors, including the quality of labelling of the test load, the representative nature of the samples, and the variations in the physiological and nutritional status of the experimental subjects (Heaney et al., 1988) . Moreover, this technique is more expensive The values that share the same superscript-letters in identical rows are significantly different. (Zerwekh et al., 1981) . The calculation of AUC did not bring more useful data than the analysis of crude values. However, owing to the large variability of the 24 h urinary calcium excretion, that parameter cannot be used as a marker of bioavailability as well as a dual stable calcium isotope approach; similarly, the serum AUC values cannot be considered as a measure of net absorption but may be used to assess relative calcium bioavailability between different sources as here.
In the original Pak's method, the subjects were fasting (Pak et al., 1975) , but it has been demonstrated that the prandial state exhibits an higher absorption rate (Schaafsma 1997) . Thus, we have chosen to provide a standardized breakfast with a very low amount of calcium (48.7 mg) before each oral load as other authors (Heaney et al., 1988; Fardellone et al., 1993) . In most studies using a Pak's derived method, the oral calcium dose comprised 1000-1300 mg/day; in one study, the dose was of 400 mg (Sadideen and Swaminathan, 2004) . A study has shown that there is a dose-response effect of the calcium load on serum ionized calcium and has shown that small repetitive doses of calcium kept the iPTH secretion at a lower level than a single higher dose (Karkkainen et al., 2001) ; we have used one single dose of 836 mg, which is the lower limit of the French recommended dietary allowances (Martin 2001) . The same study has shown that there was no difference for the effects of the timing on the response of iPTH to the acute oral calcium load (Karkkainen et al., 2001) . Therefore, the morning after fasting for at least 12 h was the used timing.
The acute effect of the calcium load was nearly the same for the three calcium sources with a slight increase of serum calcium, owing to an increase of urinary calcium excretion expressed by urinary calcium/creatinine ratio, and because of a decrease of serum iPTH by inhibition. These effects were greater for Glycollagen calcium than for milk calcium. According to another study (Fardellone et al., 1993) , it is interesting to observe that there is a decrease of serum iPTH after the very low calcium breakfast and the maltodextrine intake, and therefore without significant load of calcium. Then the serum iPTH decrease induced a secondary increase of serum phosphorus, mainly a decrease of s-CTX, which is a sensitive and specific marker of bone resorption. Similar cascade of events has been observed with oral calcium loads from 200 to 1300 mg in other studies (Zikan et al., 2001; Martini and Wood, 2002; Green et al., 2003; Sadideen and Swaminathan, 2004) . The initial decrease of serum phosphorus seems due to the chelation of phosphorus with calcium into the gut, followed by an increase of serum phosphorus secondary to the decrease of iPTH. The smallest decrease of serum phosphorus with Phoscalim might be due to the highest content of phosphorus in this product.
Another study has demonstrated that the protein and phosphorus content of calcium source has no effect on calcium absorption (Heaney 2000) . This may explain that although the three products did not have the same content of protein and phosphorus, there is no much difference in calcium absorption CAC and urinary calcium excretion between these products.
Glycollagen seems however the most efficient calcium source for its metabolic aspects and particularly the serum iPTH inhibition and s-CTX decrease. There is no evident explanation for this greater effect, except the fact that Glycollagen induced the highest increase of serum calcium, perhaps owing to its chemical bound to specific proteins, even if the difference was not statistically significant as compared to milk.
The decrease of s-CTX occurs with smaller calcium dose such as 200 mg in post-menopausal women (Zikan et al., 2001) or 400 mg in young subjects (Sadideen and Swaminathan, 2004) , but the inhibition of this marker is greater with 1000 mg than with 200 mg of calcium after 5 h. The nadir of the s-CTX concentration is effectively observed after 5 h (Zikan et al., 2001) . In our study, the blood samples were collected up to 6 h, so we have had the theory nadir for this decrease (Zikan et al., 2001; Green et al., 2003) . There was no difference between the groups 1 h after the calcium load. After 3 h, the most important decrease of s-CTX was observed for milk and after 6 h for Glycollagen. A part of the s-CTX decrease could be explained by the circadian variation in bone resorption (Qvist et al., 2005) or by intake of food, as was observed in maltodextrin group. It could not be attributable to an increased calcitonin secretion, since similar doses of calcium in another study did not alter serum calcitonin concentration (Reginster et al., 1993) . This marked effect implies that marine calcium sources are potently able to inhibit the bone resorption. It also means that they might prevent osteoporosis. However, there is a limitation in our study. Indeed, it is well proven that vitamin D status may influence calcium absorption (Wolf et al., 2000) and the Calcium bioavailability from marine calcium sources J-M Lecerf et al vitamin D supplementation may increase calcium excretion (Mortensen and Charles 1996) . In our study, the mean serum 25-OH D was in the normal range, but the subjects were not selected from their 25-OH D level and six subjects had values below 12 ng/ml (which is the estimated value for vitamin D deficiency): these low concentrations were probably due to the cloudy weather in our region; the lowest (6 ng/ml) was observed in a black subject (moreover well-described differences in PTH and 25 (OH) D and 1-2 (OH) 2D concentrations occur in blacks as compared to whites). But that could mean that since there is positive observed effect on calcium absorption in subjects with a low level of 25-OH D, if this status was normalized the effect of a calcium load on absorption should be better. Finally, another limitation of our conclusion is that we have compared two marine products to a calcium fortifiedmilk, to obtain high amounts of calcium, but not to standard milk and we cannot strictly extrapolate the results to milk.
Conclusion
In conclusion, these two marine calcium sources lead to an increase in serum calcium, urinary calcium and a decrease of serum iPTH and s-CTX as well as or better than calcium from milk. Therefore, a single dose of an oral morning marine load of calcium from dietary supplements added to a meal with a very low calcium intake may reduce bone resorption as assessed by s-CTX. It might be a useful mean to protect subjects against bone loss who cannot have enough dairy or non-dairy calcium. However, these acute effects cannot be translated to impair the progression of bone loss with age. Nevertheless, further long-term studies are needed to confirm these short-term results.
